Sebela Pharmaceuticals is a US pharmaceutical company with a market leading position in gastroenterology and a focus on innovation in women’s health. Braintree, a part of Sebela Pharmaceuticals, is the market leader in colonoscopy screening for over 35 years, having invented, developed and commercialized a broad portfolio of innovative prescription colonoscopy preparations and multiple gastroenterology products. Braintree also has multiple gastroenterology programs in late-stage clinical development. In addition, Sebela Women’s Health has two next generation intra-uterine devices (IUDs) for contraception in the final stages of clinical development. Sebela Pharmaceuticals has offices/operations in Roswell, GA; Braintree, MA; and Dublin, Ireland; has annual net sales of approximately $200 million; and has grown to over 320 employees through strategic acquisitions and organic growth.

Our culture is characterized by a high degree of urgency, open dialogue and collaborative discussion across all levels of the team, a willingness to challenge the “traditional” approach, and shared ownership of the organization we are building and of our results. We are all willing to step in and do whatever is needed on any given day, regardless of the title we hold. We strive to create a positive, collaborative, inclusive work environment in which all employees can learn, develop and grow.